New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
04:55 EDTGSK, GSK, AEP, AEP, MS, MS, MIC, MIC, TROW, TROW, BAC, BACEdison Electric Institute to hold a conference
International Utility Conference is being held in London, England on March 10-11.
News For GSK;AEP;MS;MIC;TROW;BAC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
January 15, 2015
16:20 EDTBACOn The Fly: Closing Wrap
Stocks on Wall Street had a see-saw trading day, with every attempt at getting the averages into positive territory being met with more selling. The market spent most of the day in negative territory, however, as the latest bank earnings reports failed to impress investors, the price of oil renewed its downtrend, and the Swiss National bank withdrew its floor support on the Swiss franc. ECONOMIC EVENTS: Internationally, Switzerland's central bank unexpectedly gave up its minimum exchange rate, sending the Swiss franc soaring against the dollar and euro and triggering wild swings in its equity markets. In the U.S., initial jobless claims rose 19K to 316K in the week ended January 10, versus expectations for 298K first-time claims. The producer price index fell 0.3% in December, versus expectations for a decrease of 0.4%. The core PPI rate rose 0.3% in the month, versus expectations for it to be up 0.1%. The Empire State index rebounded to 9.95 in January, beating expectations for a 5.0 reading for the measure of manufacturing activity in the New York area. The Philly Fed index fell 18.0 points to 6.3 in January, which was worse than the projected pullback to a reading of 18.7. WTI crude oil, the U.S. benchmark, reversed its early gains to end the trading session down 4.6% at $46.25 per barrel. COMPANY NEWS: Shares of Target (TGT) advanced $1.34, or 1.8%, to $75.67 after the retailer announced plans to stop operating stores in Canada. Target expects this decision will increase its earnings in fiscal 2015 and beyond, and increase its cash flow in fiscal 2016 and beyond. The company also raised its forecasts for Q4 U.S. comparable sales growth and adjusted earnings per share, mostly due to increased traffic and stronger-than-expected digital sales... Bank of America (BAC) slid 84c, or 5.24%, to $15.20 after reporting its fourth quarter results, while Citigroup (C), which also issued its Q4 report, dropped $1.82, or 3.71%, to $47.23. MAJOR MOVERS: Among the notable gainers was Cliffs Natural Resources (CLF), which rose 93c, or 11.94%, to $8.72 amid strength in the basic materials sector. Also benefitting the stock may have been a Bloomberg report that said an adviser to Quebec's investment arm stated that Cliffs' closed down Bloom Lake mine has attracted interest from several potential buyers. Also higher were shares of Kraft Foods (KRFT), which climbed $2.92, or 4.66%, to $65.68 after Goldman Sachs upgraded the stock to Buy and placed the shares on its Conviction List. Also of note, the Consumer Analyst Group of New York confirmed to Bloomberg that the food and beverage manufacturer canceled its upcoming conference appearance. Among the noteworthy losers was Best Buy (BBY), which dropped $5.61, or 14.06%, to $34.30 after reporting holiday growth that was lower than previous quarters, citing factors including weakness in tablets, and guiding toward comparable sales in the first half of FY16, excluding certain items, to be flat to down by a low-single digit percentage. Also lower were shares of BlackBerry (BBRY), which declined $2.49, or 19.77%, to $10.10 after the company said last night that it is not in talks with Samsung (SSNLF) about a potential merger, rebutting a Reuters report. INDEXES: The Dow fell 106.38, or 0.61%, to 17,320.71, the Nasdaq dropped 68.50, or 1.48%, to 4,570.82, and the S&P 500 declined 18.60, or 0.92%, to 1,992.67.
14:31 EDTGSKMylan launches generic Epivir-HBV tablets
Mylan (MYL) announced the U.S. launch of its Lamivudine Tablets, 100 mg, which is the generic version of GlaxoSmithKline's (GSK) Epivir-HBV. Mylan received final approval from the U.S. FDA for its Abbreviated New Drug Application for this product, which is indicated for the treatment of chronic hepatitis B virus infection associated with evidence of hepatitis B viral replication and active liver inflammation. Lamivudine Tablets, 100 mg, had U.S. sales of approximately $18.1M for the 12 months ending September 30, 2014, according to IMS Health. Currently, Mylan has 284 ANDAs pending FDA approval representing $109.1B in annual brand sales, according to IMS Health. Forty-four of these pending ANDAs are potential first-to-file opportunities, representing $29.3B in annual brand sales, for the 12 months ending June 30, 2014, according to IMS Health.
14:07 EDTBACBank of America says 800,000 customers enrolled in Apple Pay
Subscribe for More Information
12:26 EDTBACOn The Fly: Midday Wrap
Subscribe for More Information
10:13 EDTBACBank of America reports December default rate 3.13% vs. 3.08% last month
Subscribe for More Information
09:36 EDTBACActive equity options trading
Subscribe for More Information
09:31 EDTBACBank of America upgraded to Sector Perform from Underperform at Portales
Subscribe for More Information
09:21 EDTBACBank of America says funded exposure to oil/gas about $23B at end year
Subscribe for More Information
09:15 EDTBACOn The Fly: Pre-market Movers
Subscribe for More Information
09:14 EDTMSMorgan Stanley naming new managing directors, sources say, Reuters reports
Morgan Stanley CEO James Gorman and other senior executives have been calling employees named to the new class of managing directors at the bank, Reuters reports, citing sources. The bank is expected to make an announcement today with the names of the new managing directors. In 2014, Morgan Stanley named 153 new managing directors. Reference Link
09:10 EDTBACBofA CFO says Q4 noninterest expense lowest since Merrill Lynch merger
Subscribe for More Information
09:05 EDTBACBank of America sees pick-up in mortgage production in Q1 from re-fi
Subscribe for More Information
08:36 EDTGSKOncoMed enrolls first biomarker-selected patient in Notch1 antibody Phase trial
Subscribe for More Information
07:32 EDTBACBank of America down 2.2% after Q4 revenue miss
07:30 EDTBACBank of America reports Q4 FTE headcount down 2.5% from Q3
Subscribe for More Information
07:14 EDTBACBank of America CEO says bank enters 2015 'in good shape'
"In 2014, we continued to invest in our businesses while reducing expenses and resolving our most significant litigation matters. Last quarter, consumer deposits and loan originations were solid; wealth management client balances grew to $2.5 trillion; we increased lending to middle-market and large companies; and we retained a leadership position in investment banking. There's more work and tremendous opportunity ahead as we improve on the platform we've built to serve our customers and clients, and we enter 2015 in good shape to manage both the opportunities and the challenges the markets and economy will offer," said CEO Brian Moynihan.
07:09 EDTBACBank of America reports book value per share $21.32 at Dec. 31, 2014
Subscribe for More Information
07:07 EDTBACBank of America reports Q4 charge-offs $0.9B
Subscribe for More Information
07:04 EDTBACBank of America reports Q4 results include 7c per share charges
Subscribe for More Information
07:02 EDTBACBank of America reports Q4 EPS ex-charges 32c, consensus 32c
Reports Q4 revenue ex DVA/FVA $19.58B, consensus $20.94B.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use